ArticleAnnals of hematology2025

Rituximab efficacy for minimal residual disease eradication in philadelphia-negative acute lymphoblastic leukemia CD20.

Nicola Cecchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.